Weiguo Ye, Chief Operating Officer at GYRE THERAPEUTICS, INC. (GYRE), sold 2,800 shares at $6.17 ($17K) on 2026-06-11, disclosed to the SEC on 2026-06-15.
Open-market sale of $17k GYRE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| GYRE | SELL | 2026-06-08 | $219K | — | Filing → |
| GYRE | SELL | 2026-05-27 | $46K | — | Filing → |
| GYRE | SELL | 2026-05-22 | $137K | — | Filing → |